9:22 AM
Leo Group India
| ||
| TEXT-S&P rates BioMarin Pharmaceutical notes Reuters June 11 - Overview -- US biotechnology company BioMarin Pharmaceutical Inc. completed an equity offering that raised $250 million, more than doubling its cash balance, extending its ability to fund research by about one year. See all stories on this topic » | ||
| Stellar Pharmaceuticals to Present at the Bloom Burton Investor Conference June 21 MarketWatch (press release) LONDON, ONTARIO, Jun 11, 2012 (MARKETWIRE via COMTEX) -- Stellar Pharmaceuticals Inc. ("Stellar" or "the Company") (otcqb:SLXCF) (OTN:SLXCF) (pinksheets:SLXCF), an emerging Canadian specialty pharmaceutical company focused on the acquisition, ... See all stories on this topic » | ||
| BioSante Pharmaceuticals Announces New LibiGel(R) Phase III Efficacy Trials MarketWatch (press release) LINCOLNSHIRE, Ill., Jun 11, 2012 (BUSINESS WIRE) -- BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) , announced today that the Company plans to initiate two new LibiGel Phase III efficacy trials. This decision is based on an extensive analysis of previous ... See all stories on this topic » | ||
| Mountain View Pharmaceuticals Receives European Patent on Potential Long ... MarketWatch (press release) MENLO PARK, Calif., Jun 11, 2012 (BUSINESS WIRE) -- Mountain View Pharmaceuticals, Inc. ("MVP") announced today its receipt of European Patent No. 1 667 708 B1, titled "Polyethylene Glycol Conjugates of Interferon-beta-1b with Enhanced in vitro ... See all stories on this topic » | ||
| Brand Name Pharmaceutical Manufacturing in the US Industry Market Research ... San Francisco Chronicle (press release) With healthcare reform allowing more individuals to gain prescription coverage, brand-name pharmaceutical and medicine manufacturers will experience a boost in demand. The Patient Protection and Affordable Care Act of 2010 introduced a method for the ... See all stories on this topic » | ||
| Barack Obama's collaboration with pharmaceutical industry exposed Times of India WASHINGTON: In order to secure his sweeping 2010 health care reforms, US president Barack Obama's staff oversaw an unusually close collaboration with the pharmaceutical industry, documents show. Republicans in the House of Representatives have ... See all stories on this topic » | ||
| Top Image Systems Automates Purchase Order Processing for Leading German ... MarketWatch (press release) This leading provider of generic pharmaceuticals, off-patent and patent-free drugs in Germany processes its incoming purchase orders automatically using the eFLOW Purchase Order solution. By implementing this innovative solution, the company can ... See all stories on this topic » | ||
| Today's Market Driven by Key Factors - Featured Research on Yum! Brands, Inc ... MarketWatch (press release) Brands, Inc. (NYSE:YUM) and BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) . Full research reports are available to readers at: www.BollingerReport.com/index.php?sm1=YUM&sm2=BMRN . With markets in correction mode, investors are looking to quantify an ... See all stories on this topic » | ||
| Cubist Unveils Five-Year Strategic Goals MarketWatch (press release) LEXINGTON, Mass., Jun 11, 2012 (BUSINESS WIRE) -- Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) today announced the Company's five-year strategic aspirations -- Building Blocks of Growth -- at its Investor Day at the NASDAQ Market Site. See all stories on this topic » | ||
| Women Health Expert GC-Rise Sponsors Nationwide Anti-Cancer Campaign Sacramento Bee By GC-Rise Pharmaceutical Co., Ltd BEIJING, June 11, 2012 -- /PRNewswire-Asia/ -- GC-Rise Pharmaceutical Co. Ltd, in which European healthcare venture capital firm INVENTAGES holds a majority stake, has exclusively sponsored a nation-wide anti-tumor ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment